Overview

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this phase III, open-label study is to determine the safety and tolerability of cyclosporine in the treatment of dry eye syndrome.
Phase:
Phase 3
Details
Lead Sponsor:
Sirion Therapeutics, Inc.
Treatments:
Cyclosporine
Cyclosporins